Evidence map›Paper›PMID 39081802›Full record

ArticleHemaSphere2024

Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia.

Sanaa Khan, Krishnan Vp, Yamini Krishnan, Gazel Sainulabdin, Somdipa Pal, Rincy Mathews, Darshan Kataria, Kunal Sehgal, Purva Kanvinde, Lashkari Harshaprasad and 4 more

Abstract read
In one paragraph

Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sanaa KhanDepartment of Blood and Marrow Transplant Bai Jerbai Wadia Hospital for Children Mumbai India.
Krishnan VpDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplantation MVR Cancer Centre Kozhikode India.
Yamini KrishnanDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplantation MVR Cancer Centre Kozhikode India.
Gazel SainulabdinDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplantation MVR Cancer Centre Kozhikode India.
Somdipa PalDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplantation MVR Cancer Centre Kozhikode India.
Rincy MathewsDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplantation MVR Cancer Centre Kozhikode India.
Darshan KatariaDepartment of Blood and Marrow Transplant Bai Jerbai Wadia Hospital for Children Mumbai India.
Kunal SehgalSehgal Path Lab Mumbai India.
Purva KanvindeDepartment of Pediatric Haematology-Oncology Bai Jerbai Wadia Hospital for Children Mumbai India.
Lashkari HarshaprasadDepartment of Paediatric Haematology-Oncology Kasturba Medical College Mangalore India.
Minnie BodhanwalaDepartment of Pediatrics Bai Jerbai Wadia Hospital for Children Mumbai USA.
Bharat AgarwalDepartment of Blood and Marrow Transplant Bai Jerbai Wadia Hospital for Children Mumbai India.
Ambreen PandrowalaDepartment of Blood and Marrow Transplant Bai Jerbai Wadia Hospital for Children Mumbai India.
Prashant HiwarkarDepartment of Blood and Marrow Transplant Bai Jerbai Wadia Hospital for Children Mumbai India.ORCID 0000-0001-7504-3521

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39081802
PMCPMC11284769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.